Bulk Pharmaceutical API Sources for PREFEST

Bulk Pharmaceutical API Sources for PREFEST

Vendor	Vendor Homepage	Vendor Sku	API Url
BenchChem		B1244045
THE BioTek		bt-1577031
RR Scientific		R394466
J&H Chemical Co.,ltd		JH485107

Bulk Active Pharmaceutical Ingredient (API) Sources for PREFEST

Last updated: February 19, 2026

PREFEST, a combination drug containing estradiol and norethindrone acetate, is used for the treatment of moderate to severe vasomotor symptoms due to menopause. The supply chain for its Bulk Active Pharmaceutical Ingredient (API) is critical for ensuring consistent product availability. This analysis identifies key manufacturers and their capabilities in producing estradiol and norethindrone acetate.

What is PREFEST and its API Requirements?

PREFEST is a Hormone Replacement Therapy (HRT) product. Its therapeutic action relies on two primary APIs:

• Estradiol: A synthetic estrogen.
• Norethindrone Acetate: A synthetic progestin.

The synthesis of these complex organic molecules requires specialized manufacturing capabilities, adherence to stringent Good Manufacturing Practices (GMP), and robust quality control systems. API manufacturers must meet the specifications set by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Key API Manufacturers for Estradiol and Norethindrone Acetate

The market for these APIs is characterized by a limited number of specialized manufacturers capable of producing high-purity, GMP-compliant material. These companies often possess expertise in steroid chemistry.

Estradiol API Manufacturers

Estradiol is produced through complex multi-step chemical synthesis. Key manufacturers include:

• Bachem AG: A Swiss company specializing in peptide, oligonucleotide, and complex molecule synthesis. Bachem has a long-standing reputation for high-quality APIs, including steroids.
• Hovione Farmaciencia, S.A.: A Portuguese company with extensive experience in the development and manufacturing of APIs, including steroidal compounds. Hovione operates multiple GMP-certified facilities.
• Pharmazell GmbH: A German manufacturer of APIs and custom synthesis services. Pharmazell has a strong portfolio in hormonal APIs.
• DSM Nutritional Products: While primarily known for nutritional ingredients, DSM also has capabilities in the synthesis of various complex molecules, including some pharmaceutical intermediates and APIs.

Norethindrone Acetate API Manufacturers

Norethindrone acetate, like estradiol, is a synthetic steroid requiring specialized production. Manufacturers often overlap with estradiol suppliers due to shared technological requirements.

• Bachem AG: Possesses the synthetic expertise for norethindrone acetate production.
• Hovione Farmaciencia, S.A.: Offers contract manufacturing services for a range of APIs, including progestins.
• Pharmazell GmbH: Another key player with a focus on hormonal APIs.
• Centrient Pharmaceuticals: Formerly Lek Pharmaceutical and Chemical Company, this company is a significant producer of steroid APIs, including norethindrone. They operate manufacturing sites in Europe and India.

Table 1: Major Bulk API Manufacturers for Estradiol and Norethindrone Acetate

Manufacturer	Location(s)	Primary APIs Produced	Notes
Bachem AG	Switzerland, USA	Estradiol, Norethindrone Acetate	Specializes in complex organic synthesis.
Hovione Farmaciencia, S.A.	Portugal, USA, China	Estradiol, Norethindrone Acetate	Strong in complex chemistry and particle engineering.
Pharmazell GmbH	Germany, India	Estradiol, Norethindrone Acetate	Focus on hormonal APIs and custom synthesis.
Centrient Pharmaceuticals	Europe, India	Norethindrone Acetate	Significant player in steroid API production.
DSM Nutritional Products	Global	Estradiol (potential)	Broader chemical synthesis capabilities.

Regulatory Landscape and GMP Compliance

API manufacturing for pharmaceuticals like PREFEST is heavily regulated. Manufacturers must demonstrate compliance with:

• Good Manufacturing Practices (GMP): Standards that ensure products are consistently produced and controlled according to quality standards. This includes facility design, equipment validation, process controls, and documentation.
• FDA and EMA Regulations: Manufacturers must undergo regular inspections by these agencies. Drug product manufacturers (e.g., the formulator of PREFEST) rely on API suppliers that have successfully passed these audits and have Drug Master Files (DMFs) or equivalent dossiers accepted by regulatory authorities.
• ICH Guidelines: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines provide harmonized standards for quality, safety, and efficacy.

The ability of an API manufacturer to provide a comprehensive and up-to-date DMF is a critical factor for pharmaceutical companies seeking to secure their supply chain. This document contains detailed information about the manufacturing process, controls, and specifications of the API.

Supply Chain Considerations and Risk Mitigation

Securing a stable supply of bulk APIs for PREFEST involves managing several risks:

• Single Source Dependency: Relying on a single manufacturer for either estradiol or norethindrone acetate creates significant vulnerability. Geopolitical instability, natural disasters, or manufacturing issues at that supplier can lead to shortages.
• Quality Deviations: Any lapse in GMP compliance can result in batch rejections, regulatory sanctions, and ultimately, product recalls, impacting patient access and brand reputation.
• Capacity Constraints: While several manufacturers produce these APIs, dedicated capacity for a specific product like PREFEST may be limited. Fluctuations in demand or the introduction of new products utilizing the same APIs can strain supply.
• Lead Times: The production of complex steroid APIs involves long synthesis routes and purification steps, leading to significant lead times from order placement to delivery.

To mitigate these risks, pharmaceutical companies typically pursue a dual-sourcing strategy. This involves qualifying at least two GMP-compliant API manufacturers for each critical API.

Dual Sourcing Strategy

A dual-sourcing strategy for PREFEST would involve identifying and qualifying:

1. Two Estradiol API Manufacturers: For example, one primary supplier and one secondary or backup supplier.
2. Two Norethindrone Acetate API Manufacturers: Similarly, a primary and a secondary supplier.

Table 2: Dual Sourcing Strategy Example for PREFEST APIs

API	Primary Manufacturer	Secondary Manufacturer
Estradiol	Bachem AG	Hovione Farmaciencia
Norethindrone Acetate	Pharmazell GmbH	Centrient Pharmaceuticals

This approach requires:

• Extensive Due Diligence: Thorough audits of potential secondary suppliers to ensure they meet all GMP, quality, and regulatory requirements.
• Technical Transfer: Transferring the manufacturing process and analytical methods to the secondary supplier, which can be a lengthy and resource-intensive process.
• Ongoing Monitoring: Continuous performance monitoring and quality oversight of both primary and secondary suppliers.

API Specifications and Quality Control

The quality of the bulk APIs is paramount. Key specifications include:

• Purity: Typically >98.5% for both estradiol and norethindrone acetate, with strict limits on individual impurities.
• Chiral Purity: Ensuring the correct stereoisomer is produced, as biological activity is highly dependent on stereochemistry.
• Residual Solvents: Limits on organic solvents used during synthesis, as defined by ICH Q3C.
• Heavy Metals: Strict limits on trace metal contamination.
• Microbial Limits: Ensuring low bioburden for APIs not produced under sterile conditions.
• Particle Size Distribution: Critical for downstream processing and dissolution characteristics of the final drug product.

Manufacturers employ a range of analytical techniques for quality control, including:

• High-Performance Liquid Chromatography (HPLC) for purity and impurity profiling.
• Gas Chromatography (GC) for residual solvents.
• Mass Spectrometry (MS) for structural elucidation of impurities.
• X-ray Diffraction (XRD) for crystalline form analysis.
• Particle Size Analysis (e.g., laser diffraction).

Manufacturing Capacity and Lead Times

The synthesis of steroid APIs is capital-intensive, requiring specialized reactors, purification equipment, and containment facilities due to the potency of these compounds.

• Estradiol Synthesis: Typically involves a multi-step process starting from diosgenin or stigmasterol, with complex oxidation and functionalization steps. The overall synthesis can take 15-20 steps.
• Norethindrone Acetate Synthesis: Also a multi-step process, often starting from a precursor like estrone or from plant-derived sterols. Key steps include acetylation and specific functional group transformations.

These complex routes contribute to significant lead times. From initial order to delivery of GMP-compliant API, manufacturers typically require:

• Development/Qualification: 12-24 months for a new supplier.
• Production Lead Time: 3-6 months for commercial batches, depending on existing production schedules and batch size.

This necessitates long-term forecasting and strategic inventory management by the drug product manufacturer.

Conclusion

The reliable supply of bulk estradiol and norethindrone acetate APIs for PREFEST depends on a robust and well-managed supply chain. Key manufacturers like Bachem AG, Hovione Farmaciencia, S.A., Pharmazell GmbH, and Centrient Pharmaceuticals possess the necessary technical expertise and regulatory compliance. Pharmaceutical companies must implement dual-sourcing strategies, conduct thorough due diligence on potential suppliers, and maintain continuous oversight to ensure the availability of these critical APIs, thereby safeguarding patient access to PREFEST.

Key Takeaways

• PREFEST relies on two critical APIs: estradiol and norethindrone acetate, both complex synthetic steroids.
• A limited number of specialized manufacturers, including Bachem AG, Hovione Farmaciencia, S.A., Pharmazell GmbH, and Centrient Pharmaceuticals, produce these GMP-compliant APIs.
• Dual sourcing is essential for mitigating supply chain risks, requiring qualification of at least two manufacturers for each API.
• Stringent regulatory adherence (GMP, FDA, EMA) and comprehensive Drug Master Files are mandatory for API suppliers.
• The complex synthesis of these steroid APIs results in long production lead times (3-6 months for commercial batches) and requires significant capital investment in manufacturing capacity.

Frequently Asked Questions

1. What is the typical purity requirement for bulk estradiol and norethindrone acetate APIs? Purity requirements generally exceed 98.5% for both estradiol and norethindrone acetate, with stringent controls on individual impurities and residual solvents.

2. How long does it typically take to qualify a new API manufacturer for estradiol or norethindrone acetate? Qualifying a new manufacturer, including technical transfer and regulatory documentation, can take between 12 to 24 months.

3. What are the primary risks associated with sourcing PREFEST APIs from a single manufacturer? Risks include vulnerability to supply disruptions from geopolitical events, natural disasters, or manufacturer-specific production issues, potentially leading to drug shortages.

4. Besides purity, what other critical quality attributes must be controlled for these steroid APIs? Critical attributes include chiral purity, limits on residual solvents and heavy metals, microbial limits, and specific particle size distributions relevant to the final drug product formulation.

5. Are there any global regions that are primary hubs for the manufacturing of steroid APIs like those used in PREFEST? Europe (Germany, Switzerland, Portugal) and increasingly, India, are significant hubs for the production of complex steroid APIs due to established chemical expertise and manufacturing infrastructure.

Citations

[1] U.S. Food and Drug Administration. (n.d.). Drug Master Files (DMFs). Retrieved from [FDA Website] [2] European Medicines Agency. (n.d.). Active substances (APIs). Retrieved from [EMA Website] [3] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (n.d.). ICH Guidelines. Retrieved from [ICH Website] [4] Bachem AG. (n.d.). Products & Services. Retrieved from [Bachem Website] [5] Hovione Farmaciencia, S.A. (n.d.). APIs. Retrieved from [Hovione Website] [6] Pharmazell GmbH. (n.d.). Products. Retrieved from [Pharmazell Website] [7] Centrient Pharmaceuticals. (n.d.). Products. Retrieved from [Centrient Pharmaceuticals Website]